Springer Healthcare launches Medicine Matters, a new medical education website

February 15, 2017

Heidelberg | London, 15 February 2017 Springer Healthcare launches Medicine Matters, a new medical education website. The content-rich portal will provide physicians and healthcare professionals with a reliable, free source of medical education, designed to promote best clinical practice and improved health outcomes. The website currently focuses on the latest advances in diabetes medicine at diabetes.medicinematters.com. The global rollout plan includes local language-supported content within new websites for oncology, cardiology, rheumatology, and CNS. They will be launched in key markets including the USA, the UK, Spain, India, Mexico, and China throughout 2017 and 2018.

Medicine Matters is aimed at the healthcare professional who wants a breadth of resources to support diagnosis and optimal treatment of major disease states. Underpinned by the scientific integrity of an independent, international editorial board, the website provides expert insights and commentaries around peer-reviewed educational content. Also included are journal article synopses, themed collections, "Ask the Expert," and eLearning modules.

Additional features include access to full journal articles and conference coverage, informed and extensive monitoring of peer-reviewed research, and headline summaries for time-stressed professionals on the most topical clinical information available. The clean, practical website interface works effectively on all devices and was developed by thorough testing with thousands of healthcare professionals.

Carolyn Honour, Managing Director of Springer Healthcare, said, "Healthcare professionals across the globe are constantly learning and striving to improve their clinical knowledge. Our hope is that Medicine Matters will be the go-to reference tool within their daily practice and support improved patient outcomes."
-end-
Springer Healthcare is part of the Springer Nature group, a leading global research, educational and professional publisher. Springer Healthcare has four communication and education brands with over 40 years' experience working with the pharmaceutical industry. They are specialists in delivering innovative medical content and communications solutions, with products and services including scientific communications, medical education, promotional marketing programs, and pharmaceutical sales-force training. Springer Healthcare provides customized content development utilizing innovative online and mobile solutions that fit the specific needs and objectives of their clients. Visit http://www.springerhealthcare.com.

Springer

Related Diabetes Articles from Brightsurf:

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.